Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.4 CHF | +0.71% | -1.04% | -10.10% |
01:58pm | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Apr. 25 | The specter of stagflation rears its ugly head again |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG